BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tan G, Baby B, Zhou Y, Wu T. Emerging Molecular Markers Towards Potential Diagnostic Panels for Lupus. Front Immunol 2021;12:808839. [PMID: 35095896 DOI: 10.3389/fimmu.2021.808839] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Laigle L, Chadli L, Moingeon P. Biomarker-driven development of new therapies for autoimmune diseases: current status and future promises. Expert Rev Clin Immunol 2023;19:305-14. [PMID: 36680799 DOI: 10.1080/1744666X.2023.2172404] [Reference Citation Analysis]
2 El-Akhras BA, Talaat RM, El-Masry SA, Bassyouni IH, El-Sayed IH, Ali YB. Crosstalk between miR-146a and pro-inflammatory cytokines in patients with systemic lupus erythematosus. Int J Immunopathol Pharmacol 2023;37:3946320231154998. [PMID: 36740569 DOI: 10.1177/03946320231154998] [Reference Citation Analysis]
3 Romero-Ramírez S, Sosa-Hernández VA, Cervantes-Díaz R, Carrillo-Vázquez DA, Meza-Sánchez DE, Núñez-Álvarez C, Torres-Ruiz J, Gómez-Martín D, Maravillas-Montero JL. Salivary IgA subtypes as novel disease biomarkers in systemic lupus erythematosus. Front Immunol 2023;14:1080154. [PMID: 36911711 DOI: 10.3389/fimmu.2023.1080154] [Reference Citation Analysis]
4 Perl A, Agmon-Levin N, Crispín JC, Jorgensen TN. Editorial: New biomarkers for the diagnosis and treatment of systemic lupus erythematosus. Front Immunol 2022;13:1009038. [PMID: 36311710 DOI: 10.3389/fimmu.2022.1009038] [Reference Citation Analysis]
5 Häyry A, Faustini F, Zickert A, Larsson A, Niewold TB, Svenungsson E, Oke V, Gunnarsson I. Interleukin (IL) 16: a candidate urinary biomarker for proliferative lupus nephritis. Lupus Sci Med 2022;9:e000744. [PMID: 36104119 DOI: 10.1136/lupus-2022-000744] [Reference Citation Analysis]